Interview. Cancer immunotherapy: a realistic appraisal.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000912:Antibodies, Neoplasm; D006801:Humans; D007116:Immunization, Passive; D007121:Immunocompetence; D007165:Immunosuppression Therapy; D007167:Immunotherapy / Q000379:methods*; D007372:Interferons / Q000627:therapeutic use; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D014612:Vaccines
D000276:Adjuvants, Immunologic; D000912:Antibodies, Neoplasm; D014612:Vaccines; D007372:Interferons